ALPS Medical Breakthroughs ETF
SBIO
NYSE Arca
| Weiss Ratings | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Weak | |||
| Reward Grade | D+ | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Valuation | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Price | $32.69 | |||
| Company Info | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | ALPS | |||
| Manager/Tenure (Years) | Ryan Mischker (10), Andrew Hicks (9), Charles Perkins (1) | |||
| Website | http://www.alpsfunds.com | |||
| Phone Number | 866-759-5679 | |||
| Fund Information | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | ALPS Medical Breakthroughs ETF | |||
| Category | Health | |||
| Sub-Category | Healthcare Sector Equity | |||
| Prospectus Objective | Specialty - Health | |||
| Inception Date | Dec 30, 2014 | |||
| Open/Closed To New Investors | Open | |||
| Minimum Initial Investment | -- | |||
| Minimum Subsequent Investment | -- | |||
| Front End Fee | -- | |||
| Back End Fee | -- | |||
| Dividends and Shares | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 3.90% | |||
| Dividend | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 0.00% | |||
| Asset Allocation | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | 0.02% | |||
| Stock | 99.98% | |||
| U.S. Stock | 88.36% | |||
| Non-U.S. Stock | 11.62% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.00% | |||
| Convertible | 0.00% | |||
| Other Net | 0.00% | |||
| Price History | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -1.47% | |||
| 30-Day Total Return | 6.58% | |||
| 60-Day Total Return | 8.57% | |||
| 90-Day Total Return | 9.20% | |||
| Year to Date Total Return | -1.34% | |||
| 1-Year Total Return | -4.71% | |||
| 2-Year Total Return | 8.00% | |||
| 3-Year Total Return | 13.83% | |||
| 5-Year Total Return | -15.11% | |||
| Price | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | $32.69 | |||
| 1-Month Low Price | $30.26 | |||
| 1-Month High Price | $33.50 | |||
| 52-Week Low Price | $23.59 | |||
| 52-Week Low Price (Date) | Apr 08, 2025 | |||
| 52-Week High Price | $42.43 | |||
| 52-Week High Price (Date) | Nov 11, 2024 | |||
| NAV | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| 1-Month Low NAV | $30.28 | |||
| 1-Month High NAV | $33.51 | |||
| 52-Week Low NAV | $23.67 | |||
| 52-Week Low NAV (Date) | Apr 08, 2025 | |||
| 52-Week High NAV | $42.34 | |||
| 52-Week High Price (Date) | Nov 11, 2024 | |||
| Beta / Standard Deviation | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.86 | |||
| Standard Deviation | 26.12 | |||
| Balance Sheet | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 79.72M | |||
| Operating Ratios | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 0.50% | |||
| Turnover Ratio | 72.00% | |||
| Performance | SBIO - NYSE Arca | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 18.30% | |||
| Last Bear Market Total Return | -17.81% | |||